A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease

A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease

The objective of this position statement from the Saudi Gastroenterology Association is to guide gastroenterologists on the use of tumor necrosis factor-alfa (TNF-α) antagonists for the treatment of the idiopathic inflammatory bowel diseases, Crohn’s disease, and ulcerative colitis. In this article,...

Full description

Bibliographic Details
Main Authors: Mahmoud H Mosli, Othman Al-Harbi, Brian G Feagan, Majid A Almadi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
Crohn’s disease
inflammatory bowel disease
position statement
Saudi Gastroenterology Association
TNF antagonists
ulcerative colitis
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2015;volume=21;issue=4;spage=185;epage=197;aulast=Mosli

Internet

http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2015;volume=21;issue=4;spage=185;epage=197;aulast=Mosli

Similar Items